[go: up one dir, main page]

Jackson Huang et al., 1995 - Google Patents

Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture

Jackson Huang et al., 1995

Document ID
14461688190318371734
Author
Jackson Huang T
Brubaker P
Publication year
Publication venue
Endocrine

External Links

Snippet

Secretion of the intestinal proglucagon-derived peptides (PGDPs) including the incretin glucagon-like peptide-1 (GLP-1) is regulated, at least in part, by the duodenal hormone glucose-dependent insulinotropic peptide (GIP) through a protein kinase (PK) A-dependent …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Similar Documents

Publication Publication Date Title
Jackson Huang et al. Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture
Tucker et al. Proglucagon processing in islet and intestinal cell lines
Fehmann et al. Glucagon-like peptide-1 (7–37)/(7–36) amide is a new incretin
Mojsov et al. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
Wang et al. Glucagon-like peptide-1 is a physiological incretin in rat.
Pederson et al. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor-/-mice.
Fehmann et al. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I (7–36)-amide, oxyntomodulin, exendin-4, and exendin (9–39)
US5614492A (en) Insulinotropic hormone GLP-1 (7-36) and uses thereof
US6849708B1 (en) Insulinotropic hormone and uses thereof
Deacon Circulation and degradation of GIP and GLP-1
Nathan et al. Insulinotropic action of glucagonlike peptide-I-(7–37) in diabetic and nondiabetic subjects
Ahrén Glucagon‐like peptide‐1 (GLP‐1): a gut hormone of potential interest in the treatment of diabetes
Komatsu et al. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7–36)-amide
Deacon et al. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
Habener The incretin notion and its relevance to diabetes
Sowa et al. Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs
US7138486B2 (en) Insulinotropic hormone derivatives and uses thereof
Ritzel et al. A synthetic glucagon-like peptide-1 analog with improved plasma stability
Gerich et al. Somatostatin: physiology and clinical applications
Gallwitz et al. Binding specificity and signal transduction of receptors for glucagon-like peptide-1 (7–36) amide and gastric inhibitory polypeptide on RINm5F insulinoma cells
Fehmann et al. Insulinotropic glucagonlike peptide-I (7–37)/(7–36) amide A new incretin hormone
Nazario et al. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.
Hupe-Sodmann et al. Endoproteolysis of glucagon-like peptide (GLP)-1 (7–36) amide by ectopeptidases in RINm5F cells
Vella et al. Lack of effect of exendin-4 and glucagon-like peptide-1-(7, 36)-amide on insulin action in non-diabetic humans: A. Vella et al.: Exendin-4 and insulin actions
Siegel et al. Comparison of the effect of GIP and GLP‐1 (7–36amide) on insulin release from rat pancreatic islets